Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
NOTE:
Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:
https://rb.gy/09bxx
Publications
February 14, 2022
Detection of Early-Stage Pancreatic Ductal Adenocarcinoma from blood...
April 1, 2021
Poster: IMMray® PanCan-d Blinded Validation Study
February 1, 2021
Poster: Commercial Test Model Study – A multicenter survey
January 1, 2021
Poster: Optimization Study – Differentiating pancreatic cancer from ...
December 23, 2020
Proteomic Data Analysis for Differential Profiling of the Autoimmune...
November 21, 2019
The European Commission article on Immunovia’s IMMray PanCan-d test ...
July 24, 2019
Poster presentation: Differentiating Pancreatic Ductal Adenocarcinoma ...
August 14, 2018
Serum biomarker signature-based liquid biopsy for diagnosis of...
June 28, 2018
Poster presentation: Diagnosis of early stage pancreatic ductal...
February 3, 2017
Precision diagnostics: moving towards protein biomarker signatures of ...
October 23, 2016
Plasma protein profiling in a stage defined pancreatic cancer cohort...
July 1, 2016
Technical Advances of the Recombinant Antibody Microarray Technology...
1
2
3
4
>
Home
Publications
